|Articles|April 1, 2019
- BioPharm International-04-01-2019
- Volume 32
- Issue 4
BioPharm International, April 2019 Issue (PDF)
Click the title above to open the BioPharm International April 2019 issue in an interactive PDF format.
Advertisement
Articles in this issue
almost 7 years ago
Cleaning Chromatography Resin Residues from Surfacesalmost 7 years ago
Channeling Customer Complaints into Qualityalmost 7 years ago
Continuous Manufacturing Gains Major Push from FDAalmost 7 years ago
Reinventing the Biomanufacturing Wheelalmost 7 years ago
Continuous Bioprocessing of Vaccinesalmost 7 years ago
Leveraging Computational Models of Glycosylation for Biopharma QAalmost 7 years ago
Going Global in Biopharma Regulatory Affairsalmost 7 years ago
Predictability Improves Prospects for Biopharma Patent Holdersalmost 7 years ago
What’s New in Downstream Processingalmost 7 years ago
Changing Perceptions: An Understanding of Lyophilization AdvancementsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform
2
How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs
3
FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101
4
High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows
5
